U.S. FDA Commissioner says agency seeks fast review of COVID-19 products

U.S. FDA Commissioner says agency seeks fast review of COVID-19 products
Reuters: Health
The U.S. Food and Drug Administration is seeking to review treatments and tests for COVID-19 "as fast as we can" for emergency clearance, with the priority on those using high-level science, the agency’s commissioner said on Wednesday.